Clinical and Diagnostic Laboratory Immunology, March 1999, p. 266-268, Vol. 6, No. 2
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Variants of a Cryptococcus neoformans
Strain Elicit Different Inflammatory Responses in Mice
Lin-Chi
Chen1 and
Arturo
Casadevall1,2,*
Department of Microbiology and
Immunology1 and Division of Infectious
Diseases, Department of Medicine,2 Albert
Einstein College of Medicine, Bronx, New York 10461
Received 10 November 1998/Accepted 21 December 1998
 |
ABSTRACT |
The virulence of Cryptococcus neoformans isolates with
high and low extracellular proteolytic activity was investigated in mice. No consistent relationship between proteolytic activity and
virulence was observed, but isolates derived from one strain were shown
to elicit different inflammatory responses.
 |
TEXT |
Cryptococcus neoformans
infections are notorious for eliciting very different types of
inflammatory responses in both immunocompromised and immunocompetent
hosts (5, 11). The host and fungus variables responsible for
the protean inflammatory responses to C. neoformans infection are not understood. C. neoformans produces a
variety of extracellular enzymes and proteinases (1, 3, 4)
which may be associated with virulence and could conceivably influence the inflammatory response. Histological studies have shown degeneration of collagen fibrils in the tissue of mice infected with C. neoformans, suggesting that proteolytic activity could promote
tissue destruction (10). Proteases have been suggested as
possible virulence factors for C. neoformans (2),
but their role in virulence has not been experimentally investigated.
C. neoformans has extracellular proteolytic activity
associated with proteins of ~200, 100, and 50 kDa and can grow in
media containing protein as the sole source of nitrogen and carbon
(3). Here, we investigate the relationship between
inflammatory response, virulence, and proteolytic activity for seven
isolates of one strain which arose through spontaneous microevolution
in different laboratories (7).
Strain 24067 originated from the American Type Culture Collection.
Isolates 24067-A, 24067-B, 24067-E, and 24067-G were obtained from four
different laboratories and differ in extracellular proteolytic activity
as well as other characteristics (Table
1). Isolates 5B, 29A, and 29B are mutants
of strain 24067-A generated by irradiation with 65,000 µJ of 254 nm-light (UV Stratalinker 1800; Stratagene, La Jolla, Calif.) and
selected after replica-plating onto protein agar plates (3).
Capsule size and proteolytic activity of the strain 24067 isolates were
measured and normalized for colony size, and melanization was
determined as previously described (7). Doubling times were
calculated by plotting CFU (1 colony = 1 CFU) data as a function
of time and curve fitting the data using SigmaPlot version 2.03 (Jandel
Scientific, San Rafael, Calif.). Adult female A/J Cr mice were
purchased from the National Cancer Institute (Frederick, Md.) and
infected by either intraperitoneal (i.p.) or intratracheal (i.t.)
inoculation with 0.5 × 108 to 1 × 108 or 4 × 105 cells, respectively, as
described previously (6, 8). At various times after
infection, mice were killed and organs were removed for CFU counts and
histopathology as described (7).
Extracellular proteolytic activity was measured at days 7 and 14 of
growth in agar plates (Table 1). At day 14, the relative activity was
29B
29A > 24067-B > 24067-A
24067-E > 24067-G > 5B, levels which were statistically significant
(P < 0.05; Bonferroni t test). Mice
infected i.t. with isolates 24067-B and 24067-E had higher lung fungal
burdens than those infected with isolate 24067-G, but there was no
significant difference in liver CFUs (Table 1). Isolates 24067-E and -G
had comparable mean survival times and extrapulmonary dissemination
despite significant differences in extracellular proteolytic activity
(Fig. 1; Table 1). Mice infected with
isolates 24067-B or -E had comparable mean survival times following
i.p. infection (7) but i.t. infection revealed significant
mean survival differences (Fig. 1). The UV-induced mutants were
generated before we learned that isolate 24067-A had reduced virulence
(7), and we limited our virulence studies to measuring liver
and lung CFUs after i.p. infection. The relative order of organ fungal
burdens at day 4 of i.p. infection was 24067-A > 29B > 5B > 29A for both lung and liver tissue CFUs (Table 1). For
isolate 24067-A and its variants derived by UV mutagenesis, differences
in capsule thickness, doubling time, and extracellular proteolytic
activity did not correlate with organ CFU burden.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Survival of A/J Cr mice after i.t. infection with 4 × 105 cells of isolate 24067-B, -E, or -G. Mean survival
times of mice infected with 24067-B, -E, and -G were 39.5, 94, and 94 days, respectively. The mean survival of mice infected with 24067-B was
significantly different from the others (P = 0.0033
versus 24067-E; P = 0.0257 versus 24067-G [log rank
test]). Seven and five mice remained alive from groups E and G,
respectively, at the termination of the experiment and were censored.
There was no difference between strains 24067-E and -G (P = 0.36; log rank test).
|
|
Histological examination of lung tissue from mice infected with
isolates 24067-B, -E, and -G revealed surprising differences in the
inflammatory response. Infection with 24067-G elicited significantly
stronger granulomatous response with better containment of infection in
lung tissues than isolates 24067-B and -E (Fig. 2) and was associated with lower lung CFU
counts (Table 1). For 24067-B there was widespread dissemination of
cryptococci throughout the alveoli with little inflammatory response
(Fig. 2; Table 2). The extensive
involvement of lung tissue after infection with 24067-B is not likely
to be due to faster growth since this isolate has the longest doubling
time of the three (Table 1). Overall, the intensity of the
granulomatous inflammation in response to infection at day 7 with the
three isolates was 24067-G > 24067-E > 24067-B. Later the
inflammatory response to 24067-G decreased as the infection was cleared
in the lung (Table 2). Since granuloma formation is a hallmark of
cell-mediated immunity, this result strongly suggests that strain
microevolution can result in variants that trigger different immune
responses.

View larger version (95K):
[in this window]
[in a new window]
|
FIG. 2.
Histology of lung infection in A/J Cr mice at day 28 of
i.t. infection. Panels A, B, and C are photographs of the inflammatory
response to isolates 24067-B, -E, and -G, respectively. Tissue sections
were stained with mucin and counterstained with methyl yellow and iron
hematoxylin. For all panels, the tissues were photographed at a
magnification of ×50. Similar results were seen at day 7 of
infection.
|
|
We found no major differences in virulence among two independent sets
of isolates that had large differences in extracellular proteolytic
activity. For example, isolates 24067-E and -G had comparable virulence
despite major differences in proteolytic activity (Table 1). Consistent
with this finding, extracellular proteolytic activity is not a constant
characteristic of virulent clinical strains. For example, strain 371 (serotype A) has almost no extracellular proteolytic activity
(3) yet is highly virulent in mice (9). Another
recent clinical isolate, J32, has no detectable extracellular
proteolytic activity yet is virulent in humans and mice (unpublished
observations). The apparent lack of association between extracellular
proteolytic activity and virulence must be considered in the context of
the limitations of this study which include (i) the analysis of only a
single strain; (ii) the possibility that the animal model used may not
have been sufficiently sensitive to demonstrate differences in survival
for mice infected with isolates having high and low extracellular
proteolytic activity; and (iii) the possibility that the isolates may
not be isogenic because of microevolution or mutagenesis.
Nevertheless, we note that isolate 24067-G had the lowest extracellular
proteolytic activity and elicited the most intense inflammatory
response. Conversely, isolate 24067-B had the highest extracellular
proteolytic activity and elicited the least inflammation. Proteolytic
activity could conceivably interfere with inflammatory responses by
destroying molecules necessary for cellular recruitment, such as
cytokines, chemokines, and adhesion molecules. However, any inferences
regarding the relationship between isolate characteristics and
virulence properties must be made cautiously because these isolates
manifested several differences (Table 1). Our data show that isolates
from a single strain can elicit different inflammatory responses and suggest the need for additional studies to explore the role of proteases in cryptococcal pathogenesis.
 |
ACKNOWLEDGMENTS |
Thanks to J. Rivera for assistance in mouse infections and J. Bermudez for expertise in histochemistry.
L.-C.C. was supported in part by NIH-5T32GM07491. A.C. was supported by
NIH grants AI33774, AI3342, and HL59842 and by a Burroughs Wellcome
Development Therapeutics Award. The authors gratefully acknowledge this support.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Albert Einstein
College of Medicine, 1300 Morris Park Ave., Golding 701, Bronx, NY 10461-2187. Phone: (718) 430-4259. Fax: (718) 430-8701. E-mail: casadeva{at}aecom.yu.edu.
 |
REFERENCES |
| 1.
|
Brueske, C. H.
1986.
Proteolytic activity of a clinical isolate of Cryptococcus neoformans.
J. Clin. Microbiol.
23:631-633[Abstract/Free Full Text].
|
| 2.
|
Buchanan, K. L., and J. W. Murphy.
1998.
What makes Cryptococcus neoformans a pathogen?
Emerg. Infect. Dis.
4:71-83[Medline].
|
| 3.
|
Chen, L.-C.,
E. Blank, and A. Casadevall.
1996.
Extracellular proteinase activity of Cryptococcus neoformans.
Clin. Diagn. Lab. Immunol.
3:570-574[Abstract].
|
| 4.
|
Chen, L.-C.,
L. Pirofski, and A. Casadevall.
1997.
Extracellular proteins of Cryptococcus neoformans and host antibody response.
Infect. Immun.
65:2599-2605[Abstract].
|
| 5.
|
Fazekas, G., and J. Schwarz.
1958.
Histology of experimental murine cryptococcosis.
Am. J. Pathol.
34:517-529.
|
| 6.
|
Feldmesser, M., and A. Casadevall.
1997.
Effect of serum IgG1 against murine pulmonary infection with Cryptococcus neoformans.
J. Immunol.
158:790-799[Abstract].
|
| 7.
|
Franzot, S. P.,
J. Mukherjee,
R. Cherniak,
L. Chen,
J. S. Hamdan, and A. Casadevall.
1998.
Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes.
Infect. Immun.
66:89-97[Abstract/Free Full Text].
|
| 8.
|
Mukherjee, J.,
G. Nussbaum,
M. D. Scharff, and A. Casadevall.
1995.
Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B-cell.
J. Exp. Med.
181:405-409[Abstract/Free Full Text].
|
| 9.
|
Mukherjee, J.,
M. D. Scharff, and A. Casadevall.
1995.
Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.
Infect. Immun.
63:3353-3359[Abstract].
|
| 10.
|
Salkowski, C. A., and E. Balish.
1991.
Cryptococcosis in beige mice: the effect of congenital effects in innate immunity on susceptibility.
Can. J. Microbiol.
37:128-135[Medline].
|
| 11.
|
Schwartz, D. A.
1988.
Characterization of the biological activity of Cryptococcus infections in surgical pathology. The budding index and the carminophilic index.
Ann. Clin. Lab. Sci.
18:388-397[Abstract].
|
Clinical and Diagnostic Laboratory Immunology, March 1999, p. 266-268, Vol. 6, No. 2
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.